Pine Haven Investment Counsel’s Gilead Sciences GILD Stock Holding History

Pine Haven Investment Counsel’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$234K	Sell	1,851 -5	-0.3%	-$659	0.16%	108
2026 Q1	$259K	Hold	1,856	–	–	0.19%	98
2025 Q4	$228K	Hold	1,856	–	–	0.16%	105
2025 Q3	$206K	Hold	1,856	–	–	0.15%	113
2025 Q2	$206K	Sell	1,856 -250	-12%	-$26.6K	0.16%	109
2025 Q1	$236K	Buy	+2,106	New	+$217K	0.2%	95
2024 Q1	–	Sell	-2,539	Closed	-$206K	–	107
2023 Q4	$206K	Sell	2,539 -225	-8%	-$17.5K	0.19%	102
2023 Q3	$207K	Hold	2,764	–	–	0.21%	94
2023 Q2	$213K	Sell	2,764 -480	-15%	-$38.3K	0.21%	96
2023 Q1	$269K	Sell	3,244 -250	-7%	-$20.7K	0.28%	87
2022 Q4	$300K	Sell	3,494 -517	-13%	-$40.9K	0.33%	74
2022 Q3	$247K	Sell	4,011 -22	-0.5%	-$1.39K	0.3%	81
2022 Q2	$249K	Buy	4,033 +1	+0%	+$62	0.29%	87
2022 Q1	$240K	Sell	4,032 -218	-5%	-$13.9K	0.23%	99
2021 Q4	$309K	Buy	+4,250	New	+$293K	0.29%	85

Other funds holding GILD

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Pine Haven Investment Counsel's GILD Position: Q2 2026 in Review

Pine Haven Investment Counsel reduced its Gilead Sciences (GILD) stake by 0.27% in Q2 2026, selling an estimated $659 and leaving 1,851 shares worth $234K. The position accounts for 0.16% of the portfolio, ranked #108.

Pine Haven Investment Counsel first reported a position in GILD in Q4 2021 and has held it in 15 quarters since. The position peaked at $309K in Q4 2021. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Pine Haven Investment Counsel held 1,851 shares of Gilead Sciences worth $234K as of Q2 2026.
Pine Haven Investment Counsel sold 5 Gilead Sciences shares in Q2 2026, an estimated $659.
Gilead Sciences made up 0.16% of Pine Haven Investment Counsel's portfolio in Q2 2026, its #108 holding.
Pine Haven Investment Counsel first reported a position in Gilead Sciences in Q4 2021 and has held it in 15 quarters since.
Pine Haven Investment Counsel's Gilead Sciences position peaked at $309K in Q4 2021.
690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Pine Haven Investment Counsel's 13F filing for Q2 2026, filed 8 Jul 2026.